The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer’s Disease Mouse Models
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, SIRT2 inhibition or its genetic deletion has provided beneficial effects in different mouse models of Huntington's disease (Chopra et al., 2012;Luthi-Carter et al., 2010), Parkinson's disease (de Oliveira et al., 2017;Esteves et al., 2019;Sun et al., 2018); and Alzheimer's disease (AD) (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Biella et al., 2016
In the citing paper
“and its inhibition has shown beneficial effects in age-related neurodegenerative diseases such as AD (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020;Sola-Sevilla and Puerta, 2024).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Biella et al., 2016
In the citing paper
“These findings contrast with those previous studies showing that SIRT2 pharmacological inhibition or whole-body genetic deletion enhances learning and memory and reduces mortality and amyloid pathology in mouse models of AD (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Biella et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
Sperling, R., Mormino, E., & Johnson, K. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.038 · Cited by 725
Kuhn, P., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Roßner, S., & Lichtenthaler, S. F. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.167 · Cited by 621 · cited 1×
“had demonstrated that the 6E10 antibody could also detect human sA PP generated after cleavage in a site called ’ [24], we took the 6E10 antibody signal as suggestive of the + ’ fragments.”
BackgroundSelf-citationProteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
Green, K. N., Steffan, J. S., Martinez-Coria, H., Sun, X., Schreiber, S. S., Thompson, L. M., & LaFerla, F. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3203-08.2008 · Cited by 404 · cited 2×
“[35, 36].”
BackgroundTemporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease
Oddo, S., Caccamo, A., Tran, L., Lambert, M. P., Glabe, C. G., Klein, W. L., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507892200 · Cited by 379 · cited 1×
“Even if it is commonly acknowledged that an increase of sA PP may be protective for AD as the enzyme cleaves within the A sequence preventing its production [38], it is important not to rule out a positive effect of the sA PP itself.”
BackgroundJanelsins, M. C., Mastrangelo, M. A., Oddo, S., LaFerla, F. M., Federoff, H. J., & Bowers, W. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-23 · Cited by 260
Liu, D., Pitta, M., Jiang, H., Lee, J.-H., Zhang, G., Chen, X., Kawamoto, E. M., & Mattson, M. P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.020 · Cited by 238
Balducci, C., Mancini, S., Minniti, S., La Vitola, P., Zotti, M., Sancini, G., Mauri, M., Cagnotto, A., Colombo, L., Fiordaliso, F., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0284-14.2014 · Cited by 162
Self-citationCambray‐Deakin, M. A., & Burgoyne, R. D. (1987) · Cell Motility · doi:10.1002/cm.970080309 · Cited by 91
Research works printed but not linked: 37
- Barker, 2002, Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank, Alzheimer Dis Assoc Disord, 16, 203, 10.1097/00002093-200210000-00001 · DOI · Paper page
- Meda, 2001, Glial activation in Alzheimer’s disease: The role of Abeta and its associated proteins, Neurobiol Aging, 22, 885, 10.1016/S0197-4580(01)00307-4 · DOI · Paper page
- Craft, 2006, Insulin resistance syndrome and Alzheimer disease: Pathophysiologic mechanisms and therapeutic implications, Alzheimer Dis Assoc Disord, 20, 298, 10.1097/01.wad.0000213866.86934.7e · DOI · Paper page
- Haass, 2004, Take five–BACE and the gamma-secretase quartet conduct Alzheimer’s amyloid beta-peptide generation, EMBO J, 23, 483, 10.1038/sj.emboj.7600061 · DOI · Paper page
- Sisodia, 1990, Evidence that beta-amyloid protein in Alzheimer’s disease is not derived by normal processing, Science, 248, 492, 10.1126/science.1691865 · DOI · Paper page
- Esch, 1990, Cleavage of amyloid beta peptide during constitutive processing of its precursor, Science, 248, 1122, 10.1126/science.2111583 · DOI · Paper page
- Crowther, 1994, Assembly of Alzheimer-like filaments from full-length tau protein, FEBS Lett, 337, 135, 10.1016/0014-5793(94)80260-2 · DOI
- Goedert, 1993, Tau protein and the neurofibrillary pathology of Alzheimer’s disease, Trends Neurosci, 16, 460, 10.1016/0166-2236(93)90078-Z · DOI · Paper page
- Goedert, 1989, Amyloid plaques, neurofibrillary tangles and their relevance for the study of Alzheimer’s disease, Neurobiol Aging, 10, 405, 10.1016/0197-4580(89)90076-6 · DOI
- Goedert, 1991, Neurofibrillary tangles and beta-amyloid deposits in Alzheimer’s disease, Curr Opin Neurobiol, 1, 441, 10.1016/0959-4388(91)90067-H · DOI
- Polito, 2010, The molecular genetics of sirtuins: Association with human longevity and age-related diseases, Int J Mol Epidemiol Genet, 1, 214
- Donmez, 2012, The effects of SIRT1 on Alzheimer’s disease models, Int J Alzheimers Dis, 2012, 509529
- Chen, 2015, The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson’s disease but not amyotrophic lateral sclerosis and cerebral ischemia, PLoS One, 10, e0116919, 10.1371/journal.pone.0116919 · DOI
- Luthi-Carter, 2010, SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis, Proc Natl Acad Sci U S A, 107, 7927, 10.1073/pnas.1002924107 · DOI · Paper page
- Outeiro, 2007, Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease, Science, 317, 516, 10.1126/science.1143780 · DOI · Paper page
- Chopra, 2012, The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington’s disease mouse models, Cell Rep, 2, 1492, 10.1016/j.celrep.2012.11.001 · DOI · Paper page
- Taylor, 2011, A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase, ACS Chem Biol, 6, 540, 10.1021/cb100376q · DOI
- Polito, 2014, Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression, J Alzheimers Dis, 42, 851, 10.3233/JAD-131430 · DOI
- Oddo, 2003, Triple-transgenic model of Alzheimer’s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction, Neuron, 39, 409, 10.1016/S0896-6273(03)00434-3 · DOI · Paper page
- Colombo, 2013, Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines, Neurobiol Dis, 49, 137, 10.1016/j.nbd.2012.08.011 · DOI · Paper page
- Imbimbo, 2007, In vitro and in vivoprofiling of CHF5022 and CHF5074. Two β-amyloid1-42 lowering agents, Pharmacol Res, 55, 318, 10.1016/j.phrs.2006.12.010 · DOI
- Wisse, 2015, Hippocampal disconnection in early Alzheimer’s disease: A 7 tesla MRI study, J Alzheimers Dis, 45, 1247, 10.3233/JAD-142994 · DOI
- Moodley, 2014, The hippocampus in neurodegenerative disease, Front Neurol Neurosci, 34, 95, 10.1159/000356430 · DOI
- Mercken, 1992, Affinity purification of human tau proteins and the construction of a sensitive sandwich enzyme-linked immunosorbent assay for human tau detection, J Neurochem, 58, 548, 10.1111/j.1471-4159.1992.tb09754.x · DOI
- Mastrangelo, 2008, Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer’s disease-related pathologies in male triple-transgenic mice, BMC Neurosci, 9, 81, 10.1186/1471-2202-9-81 · DOI · Paper page
- Theendakara, 2013, Neuroprotective Sirtuin ratio reversed by ApoE4, Proc Natl Acad Sci U S A, 110, 18303, 10.1073/pnas.1314145110 · DOI · Paper page
- Polito, 2013, The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease in two Caucasian case-control cohorts, Alzheimer Dement, 9, 392, 10.1016/j.jalz.2012.02.003 · DOI
- Wei, 2014, The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease: A meta-analysis, Neuromolecular Med, 16, 448, 10.1007/s12017-014-8291-0 · DOI
- Sturchler-Pierrat, 2000, Pathogenic mechanisms of Alzheimer’s disease analyzed in the APP23 transgenic mouse model, Ann N Y Acad Sci, 920, 134, 10.1111/j.1749-6632.2000.tb06915.x · DOI · Paper page
- Almkvist, 1997, Cerebrospinal fluid levels of α-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation, Arch Neurol, 54, 641, 10.1001/archneur.1997.00550170111022 · DOI
- Taylor, 2008, Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory, Neurobiol Dis, 31, 250, 10.1016/j.nbd.2008.04.011 · DOI · Paper page
- Fragkouli, 2012, Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over-expressing MMP9, J Neurochem, 121, 239, 10.1111/j.1471-4159.2011.07637.x · DOI
- Nhan, 2015, The multifaceted nature of amyloid precursor protein and its proteolytic fragments: Friends and foes, Acta Neuropathol, 129, 1, 10.1007/s00401-014-1347-2 · DOI · Paper page
- Johnson, 1999, Tau protein in normal and Alzheimer’s disease brain: An update, J Alzheimers Dis, 1, 329, 10.3233/JAD-1999-14-512 · DOI
- Hempen, 1996, Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer’s disease, J Neuropathol Exp Neurol, 55, 964, 10.1097/00005072-199609000-00003 · DOI · Paper page
- Scuderi, 2014, Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease, Front Pharmacol, 5, 89, 10.3389/fphar.2014.00089 · DOI
- Perez, 2010, Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain, Exp Neurol, 223, 410, 10.1016/j.expneurol.2009.10.013 · DOI
Cited by
SIRT2: Controversy and multiple roles in disease and physiology
Wang, Y., Yang, J., Hong, T., Chen, X., & Cui, L. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100961 · Cited by 282
Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders
Jęśko, H., Wencel, P., Strosznajder, R. P., & Strosznajder, J. B. (2017) · Neurochemical Research · doi:10.1007/s11064-016-2110-y · Cited by 259
Sirtuins, a key regulator of ageing and age-related neurodegenerative diseases
Bhatt, V., & Tiwari, A. K. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2057849 · Cited by 28
Sola-Sevilla, N., Garmendia-Berges, M., Aleixo, M., Mera-Delgado, M., Solas, M., Tordera, R. M., García-Carracedo, L., Expósito, S., Anaya-Cubero, E., Fernández-Irigoyen, J., et al. (2025) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2025.06.016 · Cited by 5
Metadata
- Authors
- Biella, G., Fusco, F., Nardo, E., Bernocchi, O., Colombo, A., Lichtenthaler, S. F., Forloni, G., & Albani, D.
- Affiliations
- IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Department of Neuroscience, Milan, Italy
- German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2016-08-03
- Volume
- 53
- Issue
- 3
- Pages
- 1193-1207
- ISSN
- 1387-2877
- 1875-8908
- Cited by
- 78
- References
- 10
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.